Molecular profile clustering of IgE responses and potential implications for specific immunotherapy

Current Opinion in Allergy and Clinical Immunology

Volumn 13, Issue 4, 2013, Pages 438-445

  Matricardi, Paolo M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Grass pollen; IgE; Molecular allergy; Prevention; Specific immunotherapy

Indexed keywords

ALLERGEN; BERBERINE; CALCIUM BINDING PROTEIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; PATULIN; PROFILIN; RIBONUCLEASE; TRYPSIN INHIBITOR;

ALLERGY; ASTHMA; GRASS POLLEN; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOPROPHYLAXIS; IMMUNOTHERAPY; NONHUMAN; PEANUT; PHLEUM PRATENSE; POPULATION; PRIORITY JOURNAL; REVIEW; SENSITIZATION;

ALLERGENS; HUMANS; IMMUNOGLOBULIN E; IMMUNOTHERAPY; POACEAE; POLLEN; RHINITIS, ALLERGIC, SEASONAL;

EID: 84880088687     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e3283630ca5     Document Type: Review

References (37)

1. Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grasspollen immunotherapy. N Engl J Med 1999; 341: 468-475.
2. Möller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002; 109: 251-256.
3. Larsen JN, Houghton CG, Vega ML, Løwenstein H. Manufacturing and standardizing allergen extracts in Europe. Clin Allergy Immunol 2008; 21: 283-301.
4. Rossi R, Monasterolo G, Passalacqua G. The biological potency of different extracts for sublingual immunotherapy assessed by skin prick tests. Eur Ann Allergy Clin Immunol 2010; 42: 112-114.
5. Schmidt H, Gelhaus C, Nebendahl M, et al. Characterization of Phleum pratense pollen extracts by 2-D DIGE and allergen immunoreactivity. Proteomics. 2010; 10: 4352-4362.
6. Valenta R, Lidholm J, Niederberger V, et al. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999; 29: 896-904.
7. Valenta R. The future of antigen-specific immunotherapy of allergy [review]. Nat Rev Immunol 2002; 2: 446-453.
8. Andersson K, Lidholm J. Characteristics and immunobiology of grass pollen allergens. Int Arch Allergy Immunol 2003; 130: 87-107.
9. Suphioglu C. What are the most important allergens in grass pollen that are linked to human allergic disease? Clin Exp Allergy 2000; 30:1335-1341.
10. Tripodi S, Frediani T, Lucarelli S, et al. Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: implications for specific immunotherapy. J Allergy Clin Immunol 2012; 129:834-839; e8.
11. Eichler I, Soriano ES. Close collaboration between academia, industry and drug regulators is required in the development of allergen products for specific immunotherapy in children. Allergy 2011; 66: 999-1004.
12. Calderon MA, Gerth van Wijk R, Eichler I, et al. Perspectives on allergenspecific immunotherapy in childhood: an EAACI position statement. Pediatr Allergy Immunol 2012; 23: 300-306.
13. Klemans RJ, Otte D, Knol M, et al. The diagnostic value of specific IgE to Ara h 2 to predict peanut allergy in children is comparable to a validated and updated diagnostic prediction model. J Allergy Clin Immunol 2013; 131: 157-163.
14. Ebisawa M, Movérare R, Sato S, et al. Measurement of Ara h 1-, 2-, and 3-specific IgE antibodies is useful in diagnosis of peanut allergy in Japanese children. Pediatr Allergy Immunol 2012; 23: 573-581.
15. Asarnoj A, Movérare R, Ostblom E, et al. IgE to peanut allergen components: relation to peanut symptoms and pollen sensitization in 8-year-olds. Allergy 2010; 65: 1189-1195.
16. Haneda Y, Kando N, Yasui M, et al. Ovomucoids IgE is a better marker than egg white-specific IgE to diagnose boiled egg allergy. J Allergy Clin Immunol 2012; 129: 1681-1682.
17. Rossi RE, Melioli G, Monasterolo G, et al. Sensitization profiles in polysensitized patients from a restricted geographical area: further lessons from multiplexed component resolved diagnosis. Eur Ann Allergy Clin Immunol 2011; 43: 171-175.
18. Bronnert M, Mancini J, Birnbaum J, et al. Component-resolved diagnosis with commercially available D. pteronyssinus Der p 1, Der p 2 and Der p 10: relevant markers for house dust mite allergy. Clin Exp Allergy 2012; 42: 1406-1415.
19. Patelis A, Gunnbjörnsdottir M, Malinovschi A, et al. Population-based study of multiplexed IgE sensitization in relation to asthma, exhaled nitric oxide, and bronchial responsiveness. J Allergy Clin Immunol 2012; 130:397-402; e2.
20. Villalta D, Asero R. Sensitization to the pollen pan-Allergen profilin. Is the detection of immunoglobulin E to multiple homologous proteins from different sources clinically useful? J Investig Allergol Clin Immunol 2010; 20:591-595.
21. Cromwell O, Matricardi PM, Fiebig H. Patient-tailored recombinant allergen products-mission impossible? Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess 2009; 96: 210-217.
22. Cromwell O, Häfner D, Nandy A. Recombinant allergens for specific immunotherapy. J Allergy Clin Immunol 2011; 127: 865-872.
23. Jutel M, Jaeger L, Suck R, et al. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005; 116: 608-613.
24. Moverare R, Elfman L, Vesterinen E, et al. Development of new IgE reactivities to allergenic components in pollen extracts during specific immunotherapy studied with immunoblotting and the Pharmacia CAP system. Allergy 2002; 57: 423-430.
25. Asero R. Lack of de novo sensitization to tropomyosin in a group of miteallergic patients treated by house dust mite-specific immunotherapy. Int Arch Allergy Immunol 2005; 137: 62-65.
26. Asero R. Pollen specific immunotherapy is not a risk factor for de novo sensitization to cross-reacting allergens in monosensitized subjects. J Investig Allergol Clin Immunol 2006; 16: 253-257.
27. Calderón MA, Cox L, Casale TB, et al. Multiple-Allergen and single-Allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. J Allergy Clin Immunol 2012; 129: 929-934.
28. Bahceciler NN, Galip N, Cobanoglu N. Multiallergen-specific immunotherapy in polysensitized patients: where are we? Immunotherapy 2013; 5: 183-190.
29. Ciprandi G, Melioli G, Passalacqua G, Canonica GW. Immunotherapy in polysensitized patients: new chances for the allergists? Ann Allergy Asthma Immunol 2012; 109: 392-394.
30. Lee JE, Choi YS, Kim MS, et al. Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis. Ann Allergy Asthma Immunol 2011; 107: 79-84.
31. Scala E, Alessandri C, Bernardi ML, et al. Cross-sectional survey on immunoglobulin E reactivity in 23077 subjects using an allergenic moleculebased microarray detection system. Clin Exp Allergy 2010; 40: 911-921.
32. Melioli G, Marcomini L, Agazzi A, et al. The IgE repertoire in children and adolescents resolved at component level: a cross-sectional study. Pediatr Allergy Immunol 2012; 23: 433-440.
33. Lupinek C, Marth K, Niederberger V, Valenta R. Analysis of serum IgE reactivity profiles with microarrayed allergens indicates absence of de novo IgE sensitizations in adults. J Allergy Clin Immunol 2012; 130:1418-1420; e4.
34. Hatzler L, Panetta V, Lau S, et al. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol 2012; 130:894-901; e5.
35. Aalberse RC. Science from a black box. J Allergy Clin Immunol 2012; 130: 902-903.
36. Holt PG. Immunoprophylaxis of atopy: light at the end of the tunnel? Immunol Today 1994; 15: 484-489.
37. Pajno GB. Allergen immunotherapy in early childhood: between Scylla and Charybdis. Clin Exp Allergy 2005; 35: 551-553.